Although deficiencies in the retromer sorting pathway have been linked to late-onset Alzheimer's disease, whether these deficiencies underlie the disease remains unknown. Here we characterized two genetically modified animal models to test separate but related questions about the effects that retromer deficiency has on the brain. First, testing for cognitive defects, we investigated retromer-deficient mice and found that they develop hippocampaldependent memory and synaptic dysfunction, which was associated with elevations in endogenous A␤ peptide. Second, testing for neurodegeneration and amyloid deposits, we investigated retromer-deficient flies expressing human wild-type amyloid precursor protein (APP) and human ␤-site APP-cleaving enzyme (BACE) and found that they develop neuronal loss and human A␤ aggregates. By recapitulating features of the disease, these animal models suggest that retromer deficiency observed in late-onset Alzheimer's disease can contribute to disease pathogenesis.
n abnormal elevation in A␤ peptide is thought to represent a neurotoxic agent in Alzheimer's disease (1, 2) . A␤ is produced when its parent protein, the amyloid precursor protein (APP), is sequentially cleaved by two enzymes, first by BACE (␤-site APP-cleaving enzyme) and then by the multimeric ␥-secretase. APP and BACE are transmembrane proteins, and in the last few years many of the molecular mechanisms that regulate the sorting of APP and BACE through membrane compartments of the cell have been elucidated (3) . Among these, retromer sorting is a pathway recently implicated in late-onset Alzheimer's disease (LOAD) (4-7). First described in yeast, the retromer sorting pathway consists of a multimeric retromer complex-comprising VPS35, VPS26, VPS29, VPS5, and VPS17-and retromer-binding receptors, in particular VPS10 (8) (Fig. 1a) . Except for VPS17, mammalian homologues of the retromer complex have been identified (9) and are expressed in the brain among other tissue types. Mammals express a family of VPS10-containing molecules (10) , and to date two members of this family, sorLA (5, 7) and sortilin (11) , have been shown to act as retromer-binding receptors.
Three lines of evidence have implicated the retromer sorting pathway in LOAD. First, elements related to this pathway are deficient in the brains of LOAD patients, including VPS35, VPS26, and the VPS10-containing receptor sorLA (4) . Second, down-regulating any of these three elements in cell culture causes abnormal elevation of A␤ (5, 7) . Third, genetic variations in sorLA have been linked to LOAD (7) .
Although implicated in LOAD, it is unknown whether deficiencies in the retromer sorting pathway cause key features of the disease. We set out to address this issue by investigating two retromer-deficient animal models, with each model addressing separate but related questions. Because A␤ is produced in LOAD brains that express nonmutated APP, BACE, and ␥-secretase, it was important to investigate retromer deficiency on a nonmutated genetic background. To determine whether retromer deficiency causes hippocampal dysfunction, a key clinical feature of Alzheimer's disease, we began by investigating retromer deficiency in genetically modified mice. Our results suggest that retromer deficiency causes hippocampal dysfunction by elevating concentrations of endogenous A␤ peptide.
Although APP and BACE are highly homologous across species, important sequence differences do exist, and these differences can affect their intracellular transport, APP processing, and the neurotoxicity of APP end products (12) . Thus, guided by our first series of findings, it became important to investigate the effect that retromer deficiency has on a model brain expressing both human wild-type APP and human wild-type BACE. Exploiting the relative ease of modifying the Drosophila genome, we turned to flies in our second series of studies, showing that retromer deficiency increases human A␤ levels and leads to neurodegeneration.
Results

Retromer Deficiency Causes Hippocampal-Dependent Memory and
Synaptic Dysfunction. A range of behavioral, imaging, and histological studies have established that hippocampal dysfunction is a dominant clinical feature of Alzheimer's disease (13) (14) (15) . To test whether retromer deficiency causes hippocampal dysfunction we examined genetically engineered mice. First, extending studies in nonneuronal cell lines (7, 11) , we performed coimmunoprecipitation experiments in extracts from mouse brain to show that sorLA and sortilin bind VPS35, confirming that they are neuronal retromer-binding receptors (Fig. 1a) . By exploring anatomical expression maps (16), we find that genes related to the retromer complex, including VPS26 and VPS35, are highly and differentially expressed in the hippocampal formation [supporting information (SI) Fig. S1 ]. In contrast, sortilin and sorLA are diffusely expressed throughout the brain. This observation suggests that, within the retromer sorting pathway, molecules related to the retromer complex might confer hippocampal vulnerability.
To test this hypothesis, we investigated VPS26 heterozygote knockout (KO) mice that, in contrast to homozygote KO mice, survive into adulthood and do not manifest gross developmental abnormalities (17) . Western blot analysis confirmed that VPS26 protein levels are reduced in the brains of the heterozygote KO mice (ϩ/Ϫ) compared with wild-type littermates (ϩ/ϩ) (five mice per group; t ϭ 4.1, P ϭ 0.001) (Fig. 1b) . Furthermore, consistent with previous studies (18) in which a primary reduction in VPS26 causes a secondary reduction in VPS35, VPS35 protein levels were also reduced in the brains of heterozygote KO mice (five mice per group; t ϭ 2.9, P ϭ 0.01) (Fig. 1b) . Thus, the retromer-deficient state in the heterozygote KO mice is similar to that observed in the hippocampal formation of LOAD patients (5) .
To test for hippocampal-dependent memory deficits we used the modified radial-arm maze, a behavioral task used to assess the hippocampal formation in other mouse models of Alzheimer's disease (19) . Compared with wild-type littermates, the performance of the retromer-deficient mice was found to be defective [18 ϩ/ϩ and 15 ϩ/Ϫ mice; a multivariate test revealed a global effect (F ϭ 5.6, P ϭ 0.025) whereas univariate tests revealed that the effect was driven by defects at time 4 (P ϭ 0.014) and time 5 (P ϭ 0.001)] (Fig. 1c) . In contrast, both heterozygous KO mice and wild-type mice performed similarly in a visible platform task indicating normal motor, sensory, and motivational capabilities.
Memory defects observed in LOAD correlate with histological markers of hippocampal synaptic dysfunction (20) , and a range of recent studies suggest that synaptic dysfunction is an early hallmark of the disease (21, 22) . Accordingly, we used electrophysiological techniques to investigate hippocampal synaptic integrity of retromer-deficient mice. Compared with wildtype littermates, heterozygous KO mice were found to have significant defects in long-term potentiation (18 ϩ/ϩ and 16 ϩ/Ϫ mice; F ϭ 5.1, P ϭ 0.025) (Fig. 1c) with preserved paired-pulse facilitation and basal synaptic transmission.
Retromer Deficiency Elevates Levels of Endogenous A␤ in the Mouse
Brain. The hippocampal-dependent memory dysfunction observed in LOAD correlates with elevated levels of soluble, not insoluble, forms of the A␤ peptide (21) , and it is generally acknowledged that soluble forms of A␤ are neurotoxic. Compared with wild-type littermates, heterozygous KO mice were found by ELISA to have elevated brain levels of endogenous A␤40 (16 mice per group; F ϭ 11.4, P ϭ 0.002) and A␤42 (F ϭ 8.6, P ϭ 0.007) (Fig. 2a) . No difference in the level of full-length APP was observed (Fig. 2b) . To establish a stronger link between the observed elevation in A␤ and hippocampal dysfunction we replicated the electrophysiological studies and found that perfusing the slices with the ␥-secretase inhibitor L-685,458 rescued the LTP defects observed in the heterozygous KO mice (five ϩ/ϩ and six ϩ/Ϫ L-685,458-treated mice; F ϭ 0.03) (Fig. 2c) .
The elevation of both A␤40 and A␤42 observed in the retromerdeficient mice is characteristic of the profile observed in LOAD (21) , and as predicted by this profile a growing number of studies are reporting an up-regulation of BACE activity (as reviewed in ref. 23) . BACE cleaves APP into sAPP␤ and CTF␤, the membranebound C-terminal fragment that contains the A␤ sequence. ␥-Secretase then cleaves CTF␤ to liberate the A␤ peptide. In secondary analyses, we explored the profile of intermediate APP end products to assess which cleavage step is most affected by retromer deficiency. Compared with wild-type littermates, levels of sAPP␤, but not sAPP␣, were found to be elevated in the heterozygote KO mice, suggesting that retromer dysfunction increases BACE activity (24) (12 mice per group; F ϭ 4.9, P ϭ 0.038) (Fig.  2a) . CTF␤ levels, however, were not significantly elevated in the retromer-deficient mice (Fig. 2b) , suggesting that the mild increase in CTF␤ fragments induced by retromer deficiency might be fully cleaved by ␥-secretase. This interpretation is supported by our observation that sAPP␤ and averaged A␤ levels were significantly correlated among individual mice (␤ ϭ 0.47, P ϭ 0.027) (Fig. 2a) . Nevertheless, we have not excluded the possibility that retromer deficiency acts by decreasing clearance or stabilizing sAPP␤ or another APP end product.
Retromer Deficiency Elevates Levels of Human A␤ in the Fly Brain and
Causes Neurodegeneration. Although highly homologous across species, murine APP and BACE have important sequence differences from their human counterparts that affect the cell biology of APP and BACE and the toxicity of APP end products (12) . Therefore, we examined the effect of retromer deficiency in animals that express both human wild-type APP and human BACE. Because of the difficulty in engineering the complex genotype in mice, a Drosophila Alzheimer's disease model (25) in which human wild-type APP and BACE are expressed using the GAL4/UAS system (26) was used. UAS-APP and UAS-BACE were driven ubiquitously by using an actin-GAL4 (Act-GAL4) driver. These flies were crossed to line DfVPS35, which has a deletion in the Drosophila VPS35 ortholog. Sibling flies were ACT-GAL4, UAS-APP, and UAS-BACE and carried either two copies of VPS35 (ϩ/ϩ) or just one (ϩ/Ϫ), enabling us to investigate the phenotypic consequences of reducing retromer expression by 50%. To test whether retromer deficiency affects APP processing, Western blot analysis revealed that, compared with ϩ/ϩ flies, the ϩ/Ϫ flies had elevated levels of human A␤ peptide (t ϭ 4.8, P ϭ 0.009) (Fig. 3a) . Moreover, immunocytochemistry using anti-A␤ antibodies revealed that, compared with ϩ/ϩ flies, the ϩ/Ϫ flies had greater deposition of A␤ aggregates (t ϭ 6.2, P ϭ 0.001) (Fig.  3c) . A␤ accumulation was associated with a substantial reduction in lifespan in ϩ/Ϫ compared with ϩ/ϩ flies (7 days vs. 16 days at 50% survivorship) and more severe manifestation of a defect in wing vein development (25) (Fig. S2) and, most importantly, was associated with extensive neurodegeneration throughout the central brain (Fig. 3c) . At least 50% of the ϩ/Ϫ flies showed clear evidence of neurodegeneration, and a significant fraction showed dramatic loss of brain tissue. In contrast, the incidence and the severity of neurodegeneration in ϩ/ϩ flies were far less. Only Ϸ10% of these flies showed any indication of neurodegeneration, and no flies manifested the extreme tissue loss that was found regularly in the ϩ/Ϫ flies. These phenotypes are due to loss of VPS35, because comparable results were observed in flies in which DfVPS35 was replaced by a UAS-RNAi construct that specifically reduced VPS35 expression.
Discussion
Developing and characterizing animal models that express molecular defects found in early-onset Alzheimer's disease is one of the major achievements in the field (27, 28) . Nevertheless, the defects in APP or presenilins observed in early-onset Alzheimer's disease do not exist in LOAD, the form of the disease accounting for Ͼ95% of all cases. Thus, developing animal models that express molecular defects found in LOAD, on the background of nonmutated APP and presenilin, has emerged as an important goal. With this in mind, we have exploited the strengths provided by different animal models to address complementary questions about the retromerdeficient state observed in LOAD. Taken together, our findings show that deficiencies in the retromer sorting pathway can cause hippocampal dysfunction, neurodegeneration, and A␤ accumulation. By establishing that retromer-deficient animals recapitulate a number of LOAD features, these findings contribute to the growing body of evidence implicating the retromer sorting pathway in the pathogenesis of the disease. APP is a transmembrane protein that is actively sorted through many membrane compartments of the cell, and sorLA has been shown to act in APP sorting (6, 29) . Extending previous studies (7), we find that sorLA is a binding receptor of the neuronal retromer complex. Mechanistically this suggests that deficiencies in VPS26 and VPS35 accelerate A␤ production by increasing the resident time of APP within a given membrane compartment, thereby increasing its colocalization with BACE and accelerating ␤-cleavage. Future studies are required to test this proposed cellular mechanism, but it can account for why levels of both A␤40 and A␤42 are typically increased in the brains of LOAD patients even in the absence of defects in APP or BACE.
Anatomically, the differential expression pattern of VPS35 and VPS26 suggests that it is the retromer complex itself, not the retromer-binding receptors, that impose the regional vulnerability of defects in this sorting pathway. More generally, understanding why the hippocampal formation differentially expresses retromer complex molecules might provide insight into disease-related regional vulnerability. In this regard, it is interesting that numerous recent studies have shown that the retromer complex plays a role in wnt signaling (as reviewed in ref. 30 ), a morphogenic pathway that is inf luenced by presenilin (31) and that has been genetically implicated in LOAD (32) . The hippocampal formation, and in particular the entorhinal cortex (33) , have a number of distinct morphogenic features, and future studies are required to test the hypothesis 
